Tyrosine kinase oncogenes and receptors regulate cellular activities in part by stimulating the activity of serine/threonine protein kinases. Understanding the flow of regulatory information from the membrane to the cytosol and nucleus thus requires analysis of the mechanisms by which tyrosine kinases communicate with serine/threonine kinases, and of the downstream substrates and functions of these regulated kinases. This proposal is for a molecular, cellular and biochemical analysis of pp42/MAP kinase (termed herein p42mapk) which is a serine/threonine protein kinase regulated by tyrosine and threonine phosphorylations. We take advantage of a full-length P42mapk clone, knowledge of the sites of regulatory phosphorylation and a cell line in which p-42mapk regulation is defective, in order to study the molecular basis of p42mapk regulation and the cellular functions of the enzyme. We will generate regulatory and functionally altered mutants of the enzyme by site-directed mutagenesis. These will be used to study the biochemistry of p42mapk regulation and to identify and characterize regulatory factors which act upstream of the enzyme. We also will use the wild-type and mutant forms of p42mapk to identify and characterize substrates and proteins which bind to the enzyme, and which may play a role downstream from p42mapk in the signaling pathway. P42mapk was first detected as a tyrosine phosphorylated protein in cells transformed by the src oncogene and in growth factor-stimulated cells, but has since been found to become phosphorylated and activated following stimulation with various agonists of secretory, immune and neural cells. Elucidation of the regulation and function of p42mapk should thus be informative about signaling pathways utilized in a variety of cell types and responses, as well as in growth control and malignant transformation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM047332-02
Application #
3306803
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1992-05-01
Project End
1996-04-30
Budget Start
1993-05-01
Budget End
1994-04-30
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Virginia
Department
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Vomastek, Tomas; Schaeffer, Hans-Joerg; Tarcsafalvi, Adel et al. (2004) Modular construction of a signaling scaffold: MORG1 interacts with components of the ERK cascade and links ERK signaling to specific agonists. Proc Natl Acad Sci U S A 101:6981-6
Eblen, Scott T; Slack, Jill K; Weber, Michael J et al. (2002) Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes. Mol Cell Biol 22:6023-33
Gioeli, D; Zecevic, M; Weber, M J (2001) Immunostaining for activated extracellular signal-regulated kinases in cells and tissues. Methods Enzymol 332:343-53
Eblen, S T; Catling, A D; Assanah, M C et al. (2001) Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2. Mol Cell Biol 21:249-59
Carson, J P; Kulik, G; Weber, M J (1999) Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3'-kinase and Akt/protein kinase B. Cancer Res 59:1449-53
Gao, Z; Chen, T; Weber, M J et al. (1999) A2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. cross-talk between cyclic AMP and protein kinase c pathways. J Biol Chem 274:5972-80
Schaeffer, H J; Weber, M J (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 19:2435-44
Chen, T; Cho, R W; Stork, P J et al. (1999) Elevation of cyclic adenosine 3',5'-monophosphate potentiates activation of mitogen-activated protein kinase by growth factors in LNCaP prostate cancer cells. Cancer Res 59:213-8
Gioeli, D; Mandell, J W; Petroni, G R et al. (1999) Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res 59:279-84
Schaeffer, H J; Catling, A D; Eblen, S T et al. (1998) MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281:1668-71

Showing the most recent 10 out of 29 publications